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tion and platelet reactivity could play an important role in the occurrence of
stroke during the acute phase of MI. We aimed to investigate the relation-
ship between the mean platelet volume (MPV), a parameter of platelet func-
tion, the C-reactive protein (CRP), and the occurrence of in-hospital
ischemic stroke (IHS) after AMI.
Methods: Data were obtained from a French regional survey for AMI,
including 5976 patients admitted in intensive care unit (ICU) between 2001
and 2010. Patients were divided in 2 groups according to the occurrence of
IHS. MPV, platelet count and CRP were routinely measured from blood
samples drawn at admission in ICU.
Results: 87 (1.4%) IHS were recorded during the hospitalization period
after admission for AMI. After Cox multivariate regression, IHS was inde-
pendently associated with history of stroke (OR: 2.26, 95% CI: 1.26-4.06,
p=0.006), LVEF<40% (OR: 1.74, 95% CI: 1.08-2.81, p=0.002), glycemia
(OR: 1.05, 95% CI:1.01-1.08, p=0.008), CRP>10mg/l (OR: 2.56, 95% CI:
1,64-4.01, p<0.001), MPV/Platelet count ratio (OR 1.04, 95% CI: 1.01-1.08,
p=0.03) and new onset atrial fibrillation (OR:1.91, 95% CI:1.12-3.24,
p=0.02). Patients developing IHS had both an increased 30-day mortality
(32.3% vs 8.3%, p<0.001) and 1-year mortality (44.4% vs 13.5%, p<0.001)
(fig.1).
Conclusions: This study describes predictive factors for IHS after AMI,
with both higher short and long-term risk of death. At hospital admission,
new biological parameters as high MPV/Platelet count ratio and high level
of CRP might help to identify patients at increased risk of IHS. Moreover,
these results provide new insights on the potential role played by increased
inflammation and platelet reactivity underlying the occurrence of stroke
after AMI.
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Background & objectives: Small dense LDL particles (sdLDL), with
greater suceptibility to oxydation, are well-recognized risk marker for coro-
nary artery disease (CAD) and type 2 diabetes mellitus. The aim of the present
study sought to separate sdLDL subfraction by heparin-magnesiun precipita-
tion method and to evaluate the possible association of low-density lipoprotein
(LDL) particle size CAD and type 2 diabetes mellitus. 
Methods: Forty eight CAD (with or without type 2 diabetes mellitus)
patients and 51 apparently healthy subjects were included in this study.
sdLDL-cholesterol (sdLDL-C) measured after heparin-magnesiun precipita-
tion. LDL-Cholesterol (LDL-C) was calculated by the Friedwald formula
and large, buoyant LDL-Cholesterol (lrgLDL-C) was estimated by subtrac-
tion. 
Results: The prevalence of sdLDL was strongly related with the CAD risk
level. However, large, buoyant LDL-C showed no significant decrease in
CAD patients. LDL-C decreased significantly in CAD without diabetes
(CADd-) when compared to controls. Its level significantly lower in CAD
with diabetes (CADd+) patients with respect to healthy and to CADd-
patients. Small density LDL-C increased significantly in coronary patients
(with or without diabetes). However, lrgLDL-C was significantly decreased only
in (CADd+) group compared to controls (0.73±0.02 vs 2.02±0.04; p= 0.03
respectively). A negative correlation (r=–0.22, p=0.03) between TG and
sdLDL-C levels was observed when all groups are geathred, and was not
found in controls and CAD patients (with or without diabetes). No correlation
could be evidenced between HDL-C and sdLDL-C concentrations in all
groups nor in CAD group. 
Conclusions: elevated sdLDL-C level may contribute to atherosclerosis
that renforce the developement of coronaropathy. The decrease of lrgLDL
seems to be attribuated to diabetes mellitus rather than to CAD. 
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Backgroud: Serum cystatin C has been proposed as a better marker of glo-
merular filtration rate than serum creatinine. This study aims to evaluate the
relationship between cystatinC, BNP and acute coronary syndrome.
Methods: A total of 127 consecutive patients with acute coronary syn-
drome (ACS) were enrolled in this study. All patients had a normal glomerular
filtration rate (GFR) estimated using the MDRD (Modification of Diet in
Renal Disease) equation.Serum cystatin C and brain natriuretic peptide (BNP)
were determined in all subjects. All patients were followed up for 12 months
and adverse cardiovascular events were recorded.
Results: Serum Cys C levels were significantly higher in patients with
multi-vessel coronary artery disease (1.17±0.47mg/L vs. 0.93±0.24mg/L,
P<0.01). BNP concentrations were significantly associated to left ventricular
ejection fraction (LVEF). Patients with systolic heart failure (LVEF < 50%)
had higher BNP levels (343.3 pg/mL vs. 212.7 pg/mL; P<0.001). Serum Cys
C and BNP levels were significantly associated to mortality and morbidity
post ACS. Receiver operator characteristic (ROC) analyses identified cys C as
being the best marker in predicting major adverse cardiac and cerebrovascular
events (MACCE: heart failure hospitalizations, recurrent ischemic events and
mortality) (AUC=0.622). For high Cys C levels (>1.2mg/L), the risk of occur-
rence of MACCE was multiplied by 3.35 for BNP levels exceeding 350pg/mL.
ROC analyses identified BNP as the best predictor of LV systolic dysfunstion
(AUC = 0.784). A BNP value exceeding 133pg/mL had a sensibility of
83% and a specificity of 67% for predicting LV systolic dysfunction
during follow-up.
Conclusions: Cystatin C and BNP are strong predictors for risk of cardio-
vascular events in acute coronary syndrome. 
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